Exterran Corporation (EXTN) Fundamental Analysis & Valuation

NYSE:EXTN • US30227H1068

Current stock price

4.58 USD
-0.26 (-5.37%)
At close:
4.66 USD
+0.08 (+1.75%)
After Hours:

This EXTN fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. EXTN Profitability Analysis

1.1 Basic Checks

  • EXTN had negative earnings in the past year.
  • In the past year EXTN had a positive cash flow from operations.
EXTN Yearly Net Income VS EBIT VS OCF VS FCFEXTN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 0 100M -100M 200M -200M

1.2 Ratios

Industry RankSector Rank
ROA -6.56%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
EXTN Yearly ROA, ROE, ROICEXTN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 0 -20 -40 -60

1.3 Margins

Industry RankSector Rank
OM -0.45%
PM (TTM) -11.16%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
EXTN Yearly Profit, Operating, Gross MarginsEXTN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 0 20 -20 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. EXTN Health Analysis

2.1 Basic Checks

  • EXTN does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, EXTN has more shares outstanding
  • The debt/assets ratio for EXTN is higher compared to a year ago.
EXTN Yearly Shares OutstandingEXTN Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 10M 20M 30M
EXTN Yearly Total Debt VS Total AssetsEXTN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 500M 1B 1.5B

2.2 Solvency

  • EXTN has an Altman-Z score of 0.13. This is a bad value and indicates that EXTN is not financially healthy and even has some risk of bankruptcy.
  • EXTN has a Debt/Equity ratio of 4.65. This is a high value indicating a heavy dependency on external financing.
Industry RankSector Rank
Debt/Equity 4.65
Debt/FCF N/A
Altman-Z 0.13
ROIC/WACCN/A
WACC8.73%
EXTN Yearly LT Debt VS Equity VS FCFEXTN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 0 200M 400M

2.3 Liquidity

  • A Current Ratio of 1.29 indicates that EXTN should not have too much problems paying its short term obligations.
  • EXTN has a Quick Ratio of 1.05. This is a normal value and indicates that EXTN is financially healthy and should not expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 1.29
Quick Ratio 1.05
EXTN Yearly Current Assets VS Current LiabilitesEXTN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 100M 200M 300M 400M 500M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. EXTN Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 20.62% over the past year.
  • EXTN shows a strong growth in Revenue. In the last year, the Revenue has grown by 26.06%.
  • The Revenue has been decreasing by -6.99% on average over the past years.
EPS 1Y (TTM)20.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%74.7%
Revenue 1Y (TTM)26.06%
Revenue growth 3Y-22.63%
Revenue growth 5Y-6.99%
Sales Q2Q%51.35%

3.2 Future

  • EXTN is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 0.59% yearly.
  • The Revenue is expected to grow by 7.28% on average over the next years.
EPS Next Y-6.04%
EPS Next 2Y11.47%
EPS Next 3Y3.16%
EPS Next 5Y0.59%
Revenue Next Year42.26%
Revenue Next 2Y24.76%
Revenue Next 3Y12.67%
Revenue Next 5Y7.28%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
EXTN Yearly Revenue VS EstimatesEXTN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 500M 1B 1.5B
EXTN Yearly EPS VS EstimatesEXTN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 -1 -2 -3

More info and screens

Find the best growth stocksShow best growing peers

0

4. EXTN Valuation Analysis

4.1 Price/Earnings Ratio

  • EXTN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year EXTN is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
EXTN Price Earnings VS Forward Price EarningsEXTN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 4.81
EXTN Per share dataEXTN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y11.47%
EPS Next 3Y3.16%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. EXTN Dividend Analysis

5.1 Amount

  • EXTN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

EXTN Fundamentals: All Metrics, Ratios and Statistics

Exterran Corporation

NYSE:EXTN (10/12/2022, 8:14:15 PM)

After market: 4.66 +0.08 (+1.75%)

4.58

-0.26 (-5.37%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryEnergy Equipment & Services
Earnings (Last)08-09
Earnings (Next)11-01
Inst Owners0%
Inst Owner Change0%
Ins Owners1.06%
Ins Owner Change0%
Market Cap153.41M
Revenue(TTM)760.90M
Net Income(TTM)-84.93M
Analysts82.86
Price Target9.69 (111.57%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-38.09%
Min EPS beat(2)-148.37%
Max EPS beat(2)72.18%
EPS beat(4)2
Avg EPS beat(4)-49.95%
Min EPS beat(4)-166.54%
Max EPS beat(4)72.18%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)1.1%
Min Revenue beat(2)-3.62%
Max Revenue beat(2)5.82%
Revenue beat(4)1
Avg Revenue beat(4)-3.1%
Min Revenue beat(4)-8.7%
Max Revenue beat(4)5.82%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.2
P/FCF N/A
P/OCF 38.77
P/B 1.04
P/tB 1.73
EV/EBITDA 4.81
EPS(TTM)-2.31
EYN/A
EPS(NY)-2.29
Fwd EYN/A
FCF(TTM)-2.6
FCFYN/A
OCF(TTM)0.12
OCFY2.58%
SpS22.72
BVpS4.39
TBVpS2.64
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -6.56%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM -0.45%
PM (TTM) -11.16%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.59
Health
Industry RankSector Rank
Debt/Equity 4.65
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 55.44%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 102.45%
Current Ratio 1.29
Quick Ratio 1.05
Altman-Z 0.13
F-Score5
WACC8.73%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)20.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%74.7%
EPS Next Y-6.04%
EPS Next 2Y11.47%
EPS Next 3Y3.16%
EPS Next 5Y0.59%
Revenue 1Y (TTM)26.06%
Revenue growth 3Y-22.63%
Revenue growth 5Y-6.99%
Sales Q2Q%51.35%
Revenue Next Year42.26%
Revenue Next 2Y24.76%
Revenue Next 3Y12.67%
Revenue Next 5Y7.28%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-1350.17%
FCF growth 3YN/A
FCF growth 5Y-50.27%
OCF growth 1Y-96.14%
OCF growth 3Y-33.95%
OCF growth 5Y-29.67%

Exterran Corporation / EXTN Fundamental Analysis FAQ

What is the fundamental rating for EXTN stock?

ChartMill assigns a fundamental rating of 3 / 10 to EXTN.


Can you provide the valuation status for Exterran Corporation?

ChartMill assigns a valuation rating of 3 / 10 to Exterran Corporation (EXTN). This can be considered as Overvalued.


Can you provide the profitability details for Exterran Corporation?

Exterran Corporation (EXTN) has a profitability rating of 1 / 10.